Within a new study, we documented the identification as well as the characterization of a completely new atypical opioid receptor with unique detrimental regulatory properties in the direction of opioid peptides.1 Our final results showed that ACKR3/CXCR7, hitherto called an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can https://jackh057jje7.therainblog.com/profile